Tenon Medical Stock Fundamentals

TNON Stock  USD 3.75  2.77  282.65%   
Tenon Medical fundamentals help investors to digest information that contributes to Tenon Medical's financial success or failures. It also enables traders to predict the movement of Tenon Stock. The fundamental analysis module provides a way to measure Tenon Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tenon Medical stock.
Depreciation And AmortizationInterest Expense
At this time, Tenon Medical's Cost Of Revenue is very stable compared to the past year. As of the 25th of March 2025, Total Operating Expenses is likely to grow to about 20.5 M, while Interest Expense is likely to drop about 22.9 K.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tenon Medical Company Return On Equity Analysis

Tenon Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Tenon Medical Return On Equity

    
  -4.05  
Most of Tenon Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tenon Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Tenon Total Stockholder Equity

Total Stockholder Equity

939,435

At this time, Tenon Medical's Total Stockholder Equity is very stable compared to the past year.
Based on the latest financial disclosure, Tenon Medical has a Return On Equity of -4.0519. This is 83.1% lower than that of the Health Care Equipment & Supplies sector and 53.59% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Tenon Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tenon Medical's current stock value. Our valuation model uses many indicators to compare Tenon Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tenon Medical competition to find correlations between indicators driving Tenon Medical's intrinsic value. More Info.
JavaScript chart by amCharts 3.21.15DYNTSGHTASAPFMOVEAIMDSSKNTNON -1.2-1.0-0.8-0.6-0.4-0.20 -4.5-4.0-3.5-3.0-2.5-2.0-1.5-1.0-0.50
Tenon Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Tenon Medical's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tenon Medical's earnings, one of the primary drivers of an investment's value.

Tenon Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tenon Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tenon Medical could also be used in its relative valuation, which is a method of valuing Tenon Medical by comparing valuation metrics of similar companies.
-4.0519-0.2578-0.4959-0.2737-1.8125100%
Tenon Medical is currently under evaluation in return on equity category among its peers.

Tenon Fundamentals

Return On Equity-4.05
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-12,000%-10,000%-8,000%-6,000%-4,000%-2,000%0%
Return On Asset-1.06
Operating Margin(4.12) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%150%200%250%300%
Current Valuation(1.72 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Shares Outstanding3.14 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Shares Owned By Insiders1.63 %
Shares Owned By Institutions4.19 %
Number Of Shares Shorted172.77 K
Price To Book0.72 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Price To Sales0.94 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%0%20%
Revenue2.93 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%1,000%2,000%3,000%4,000%5,000%6,000%
Gross Profit1.71 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,000%-1,000%0%1,000%2,000%3,000%4,000%
EBITDA(15.53 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%
Net Income(15.58 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%3,500%
Cash And Equivalents16.02 M
Cash Per Share1.42 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%7,000%
Total Debt1.86 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%
Debt To Equity0.07 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-600%-400%-200%0%
Current Ratio7.54 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Book Value Per Share0.70 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-500%0%500%1,000%
Cash Flow From Operations(12.18 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%1,000%2,000%3,000%4,000%5,000%
Short Ratio1.99 X
Earnings Per Share287.92 X
Target Price3.0
Beta1.9
Market Capitalization3.07 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Asset6.34 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Retained Earnings(55.07 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%1,400%
Working Capital6.82 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Net Asset6.34 M

About Tenon Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Tenon Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tenon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tenon Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue3.4 M3.5 M
Cost Of Revenue1.9 MM
Stock Based Compensation To Revenue 1.27  1.42 
Sales General And Administrative To Revenue 2.16  2.05 
Research And Ddevelopement To Revenue 1.24  1.18 
Capex To Revenue 0.14  0.13 
Revenue Per Share 11.62  12.20 
Ebit Per Revenue(6.18)(6.49)

Pair Trading with Tenon Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tenon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenon Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Tenon Stock

  0.88HOLX HologicPairCorr
  0.74INFU InfuSystems HoldingsPairCorr

Moving against Tenon Stock

  0.84LUCD Lucid DiagnosticsPairCorr
  0.76GOSS Gossamer BioPairCorr
  0.72OCX OncoCyte CorpPairCorr
  0.67MNDR Mobile health NetworkPairCorr
  0.51PAVM PAVmed IncPairCorr
The ability to find closely correlated positions to Tenon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tenon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tenon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tenon Medical to buy it.
The correlation of Tenon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tenon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tenon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tenon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Tenon Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenon Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenon Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenon Medical Stock:
Check out Tenon Medical Piotroski F Score and Tenon Medical Altman Z Score analysis.
To learn how to invest in Tenon Stock, please use our How to Invest in Tenon Medical guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenon Medical. If investors know Tenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
287.92
Revenue Per Share
2.699
Quarterly Revenue Growth
(0.05)
Return On Assets
(1.06)
Return On Equity
(4.05)
The market value of Tenon Medical is measured differently than its book value, which is the value of Tenon that is recorded on the company's balance sheet. Investors also form their own opinion of Tenon Medical's value that differs from its market value or its book value, called intrinsic value, which is Tenon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenon Medical's market value can be influenced by many factors that don't directly affect Tenon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 
News Freq…Investor S…